← Leaderboards
Mark E Davis
California Institute Of Technology
$4,665,766
Attributed
$6,339,093
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $959.6K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,339,093 · 6
By mechanism
R01$4,719,433 · 3
U54$1,619,660 · 3
Top collaborators
- William Andrew Goddard5 shared
- Prasadarao V Nemani5 shared
- Brian M Stoltz5 shared
Most similar at California Institute Of Technology
Same institution · by research overlap
- Brian M Stoltz$10,808,237
- Niles A Pierce$6,810,516
- William Andrew Goddard$914,695
- Theresa M Reineke$3,505,747
- Niles A Pierce$4,737,936
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoNanoparticleMonitorMutateDesignLigandsAnimal ModelTargeted DeliveryProteinsMalignant NeoplasmsBrainBiologyReceptorSmall MoleculeBlood - Brain Barrier AnatomyBaseBloodIn VitroSignal TransductionMediatingEventSurfaceAffectSmall Interfering Rna
Grant awards (22)
Project 1: Targeted Nanoparticle Therapeutics for Treating Intracranial Disease$126,781
U54 · FY2018 · CA · contact PI
Project 1: Targeted Nanoparticle Therapeutics for Treating Intracranial Disease$105,507
U54 · FY2017 · CA · contact PI
Project 1: Targeted Nanoparticle Therapeutics for Treating Intracranial Disease$42,935
U54 · FY2017 · CA · contact PI
Project 1: Targeted Nanoparticle Therapeutics for Treating Intracranial Disease$243,436
U54 · FY2016 · CA · contact PI
Brain Endothelial Cell Receptor for Escherichia coli$447,653
R01 · FY2015 · AI
Project 1: Targeted Nanoparticle Therapeutics for Treating Intracranial Disease$240,795
U54 · FY2015 · CA · contact PI
Brain Endothelial Cell Receptor for Escherichia coli$447,794
R01 · FY2014 · AI
In Vivo Pharmacodynamics of RNAi-based Cancer Therapies$166,623
U54 · FY2014 · CA · contact PI
Brain Endothelial Cell Receptor for Escherichia coli$421,057
R01 · FY2013 · AI
In Vivo Pharmacodynamics of RNAi-based Cancer Therapies$161,922
U54 · FY2013 · CA · contact PI
Brain Endothelial Cell Receptor for Escherichia coli$448,066
R01 · FY2012 · AI
A Novel Method of Nanoparticle Delivery to Brain by Targeting Ec-gp96$320,272
R01 · FY2012 · NS · contact PI
In Vivo Pharmacodynamics of RNAi-based Cancer Therapies$174,623
U54 · FY2012 · CA · contact PI
Brain Endothelial Cell Receptor for Escherichia coli$466,533
R01 · FY2011 · AI
A Novel Method of Nanoparticle Delivery to Brain by Targeting Ec-gp96$318,488
R01 · FY2011 · NS · contact PI
In Vivo Pharmacodynamics of RNAi-based Cancer Therapies$174,556
U54 · FY2011 · CA · contact PI
A Novel Method of Nanoparticle Delivery to Brain by Targeting Ec-gp96$333,206
R01 · FY2010 · NS · contact PI
In Vivo Pharmacodynamics of RNAi-based Cancer Therapies$182,482
U54 · FY2010 · CA · contact PI
Design of Gene Delivery System to Target Hepatocytes$378,593
R01 · FY2008 · EB · contact PI
Design of Gene Delivery System to Target Hepatocytes$375,069
R01 · FY2007 · EB · contact PI
Design of Gene Delivery System to Target Hepatocytes$375,019
R01 · FY2006 · EB · contact PI
Design of Gene Delivery System to Target Hepatocytes$387,683
R01 · FY2005 · EB